Shigellosis: The rise of an antibiotic-resistant stomach bug
The Centers for Disease Control and Prevention issued a health alert in February saying it was monitoring a rise in drug-resistant Shigella infections, leaving doctors concerned over what this could mean for other bacteria. Here's everything you need to know: What is Shigella? Shigella is a…#shigella #cdc #stephenbaker #times #ecoli (Source: Reuters: Health)
Source: Reuters: Health - March 16, 2023 Category: Consumer Health News Source Type: news
How to tell the difference between shigella and norovirus as stomach flus rise
Cases of norovirus - or the 'stomach flu ' - reached a 12-month high in February and are still wreaking havoc, particularly in US schools. At the same time, cases of Shigella infections are on the rise. (Source: the Mail online | Health)
Source: the Mail online | Health - March 15, 2023 Category: Consumer Health News Source Type: news
New STELARA ® (ustekinumab) Long-Term Data Support its Established Safety Profile in Inflammatory Bowel Disease and Durable Efficacy in Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, March 4, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final pooled long-term safety results for STELARA® (ustekinumab) through five years in adults with moderately to severely active Crohn’s disease (CD) and four years in adults with moderately to severely active ulcerative colitis (UC), as well as final four-year clinical and endoscopic outcomes from the UNIFI long-term extension (LTE) study evaluating the efficacy of STELARA for the treatment of adults with moderately to severely active UC.1,2 These data are a part of Janssen’s 22 oral and poster ...
Source: Johnson and Johnson - March 4, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
A ‘super strain’ of an antibiotic-resistant stomach bug is on the rise in the U.S. Here are the symptoms to watch for
Antibiotic resistance is once again making headlines—this time not involving an STD, but a brutal GI illness that can also spread sexually. In January, U.S. public health officials warned of a so-called “super strain” of gonorrhea resistant to many types of antibiotics usually used to treat it. A…#std #casesofxdr #shigella #cdc #colorado #xdrshigella #racheljervis #xdr #jervis #eating (Source: Reuters: Health)
Source: Reuters: Health - March 4, 2023 Category: Consumer Health News Source Type: news
What to know about Shigella, the drug-resistant stomach bug on the rise
A recent health advisory described these infections as a “serious public health threat.” (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - March 3, 2023 Category: Consumer Health News Authors: Lena H. Sun Source Type: news
What is Shigella, the increasingly drug-resistant bacteria the CDC is warning about?
Shigella causes shigellosis, an inflammatory diarrhea. The extensively drug-resistant strain is relatively uncommon overall, but it's being seen in more cases among adults. (Image credit: Stephanie Rossow/Science Source) (Source: NPR Health and Science)
Source: NPR Health and Science - March 3, 2023 Category: Consumer Health News Authors: Kaitlyn Radde Source Type: news
TREMFYA ® (guselkumab) Demonstrates a Differentiated Binding Mechanism from Risankizumab in In Vitro Studies
SPRING HOUSE, PENNSYLVANIA, March 3, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced additional results from in vitro MODIF-Y studies, which continue to support a hypothesis that not all IL-23 inhibitors are the same by demonstrating a differentiated binding mechanism for TREMFYA® (guselkumab) from risankizumab. Findings show that guselkumab is able to dose-dependently bind to CD64+a myeloid cells,1 the predominant source of IL-23-driven inflammation in the gut.2,b Data comprise one of Janssen’s 22 oral and poster presentations at the 18th Congress of the European Crohn’s and Col...
Source: Johnson and Johnson - March 3, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
University of Washington Researchers Use Genomic Analysis to Track Shigella Infections as Decreased Cost of Gene Sequencing Aids Public Health Research
Another study in the United Kingdom that also used genomic analysis to understand drug-resistant Shigella produced findings that may be useful for microbiologists and medical laboratory scientists From the onset of an infectious disease outbreak, public health officials, microbiologists, and clinical laboratory managers find it valuable to trace the origin of the spread back to […]
The post <strong>University of Washington Researchers Use Genomic Analysis to Track Shigella Infections as Decreased Cost of Gene Sequencing Aids Public Health Research</strong> appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - March 1, 2023 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: International Laboratory News Laboratory Pathology Laboratory Testing Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing anatomic pathology antimicrobial therapy CDC Center for Infectious Disease Research and Policy centers for Source Type: news
CDC Warns of Rise of Drug-Resistant Shigella Bacteria
MONDAY, Feb. 27, 2023 -- Public health officials are warning about an increase in drug-resistant strains of the bacteria Shigella.
About 5 percent of Shigella infections reported to the U.S. Centers for Disease Control and Prevention last year were... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 27, 2023 Category: Pharmaceuticals Source Type: news
CDC Warns of Rise of Drug-Resistant Shigella Bacteria
MONDAY, Feb. 27, 2023 -- Public health officials are warning about an increase in drug-resistant strains of the bacteria shigella.
About 5% of shigella infections reported to the U.S. Centers for Disease Control and Prevention last year were caused... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 27, 2023 Category: General Medicine Source Type: news
CDC issues warning over an increase of drug-resistant bacteria
The US Centers for Disease Control and Prevention has issued a health advisory to warn the public of an increase of a drug-resistant bacteria called Shigella. (Source: CNN.com - Health)
Source: CNN.com - Health - February 26, 2023 Category: Consumer Health News Source Type: news
Extensively Drug-Resistant Shigellosis on the Rise in the U.S.
(MedPage Today) -- Healthcare professionals should be on the lookout for an increase in extensively drug-resistant (XDR) Shigella infections (shigellosis) and should report cases to local or state health departments, the CDC said in a health advisory... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 24, 2023 Category: Primary Care Source Type: news
Norovirus Genogroup IX Outbreaks in LTC Facilities Norovirus Genogroup IX Outbreaks in LTC Facilities
Norovirus genotype GIX was identified as the cause of a cluster of acute gastroenteritis outbreaks in long term care facilities in Utah.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 23, 2023 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news
The Water Crisis No One In America Is Fixing
On Feb. 3, 2022, a train loaded with toxic chemicals derailed in East Palestine, Ohio, igniting a fire and forcing the controlled release and burn of vinyl chloride, a known cancer-causing compound, to avert a disastrous explosion. The environmental catastrophe killed thousands of fish in nearby streams and has triggered growing concerns over the impact on residents’ health and on the village’s surface, ground, and well water.
East Palestine joins a long list of other places in the United States facing major threats to clean water. In October 2022, a campaign called “Imagine a Day Without Water” ask...
Source: TIME: Health - February 16, 2023 Category: Consumer Health News Authors: Bryn Nelson Tags: Uncategorized climate change freelance Health Care Source Type: news
Norovirus Is on the Rise. What to Know About Symptoms and Treatment
While SARS-CoV-2 has dominated headlines for the past few years, other viruses have been simmering in the background. And with most of COVID-19’s infection control measures (like mask-wearing, isolation, and physical distancing) now gone in the U.S., those viruses are starting to roar back again.
The U.S. has already seen spikes in RSV and influenza, and now norovirus cases are inching upward, according to the latest data from the U.S. Centers for Disease Control and Prevention (CDC). Unlike SARS-CoV-2, RSV, and influenza, norovirus is not a respiratory pathogen but instead causes problems in the gastrointestinal tra...
Source: TIME: Health - February 10, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Public Health Source Type: news
